SAN DIEGO--(BUSINESS WIRE)--Feb. 1, 2006--Inovio Biomedical Corporation (AMEX:INO), a late stage developer of oncology and other therapies using electroporation to deliver drugs and nucleic acids, announced today that the Company's president and CEO, Avtar Dhillon, MD, will present a corporate overview on Inovio at the BIO CEO Investor Conference 2006, Wednesday, February 15th, at 2:30 p.m. EST (11:30 a.m. EST). The conference will be held at the Waldorf=Astoria, New York, February 14-15, 2006.
